Pharos Capital Launches Verdi Oncology through Horizon Oncology Acquisition

We represented Pharos Capital Group in its acquisition of Horizon Oncology. The acquisition marks the launch of Verdi Oncology, Inc., an oncology practice and clinical research management company. Financial terms of the transaction were not publicly disclosed.

Horizon Oncology offers a wide range of comprehensive cancer services to patients, including advanced technological options, premier clinical expertise and cutting edge clinical trials opportunities, with a focus on early phase trials.

Pharos Capital Group is an SEC Registered Investment Advisor. As of March 2018, Pharos has invested in 51 companies and currently has over $690 million of private equity assets under management.

You Also May Be Interested In:

  • Represented Maslow Development Inc. in connection with the acquisition and future development of 15 acres of land in Memphis, Tennessee

    We represented Maslow Development Inc. in connection with the acquisition and future development of 15 acres of land in Memphis,...
    Client Type: Private Company
  • We represented Numotion, a provider of products and services that provide mobility, health and personal independence, in its acquisition of Wheeler’s Medical Supply, a provider of intermittent catheters and incontinence supplies based in Jacksonville, Florida. Terms of the transaction were not disclosed.

    We represented Numotion, a provider of products and services that provide mobility, health and personal independence, in its acquisition of...
    Client Type: Private Company
  • Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its acquisition of SunLife Home Care, a home healthcare provider based in Tucson, Arizona

    We represented Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in...
    Client Type: Public Company